ED Coding & Reimbursement Alert - 2016 Issue 12
Reader Question: Use This E/M Risk Category For Coumadin
Subscribe or sign in to view the full article.
Article Overview
This article answers a reader question about E/M risk categorization for Coumadin management and summarizes a Medicare contractor’s position on documentation for drug therapy monitoring. It is relevant to clinicians, coders, and auditors who work with office and outpatient E/M documentation and need to understand how payer guidance may affect medical decision-making risk assessment.
Why This Topic Matters
E/M leveling depends on accurate risk documentation, and payer interpretations can influence how encounters are supported in the record. This short article helps readers understand where to look for guidance and why the provider’s assessment and documentation matter.
Article Sections
-
Question
Introduces the reader’s question about E/M risk assessment for prescription drug management.
-
Answer
Summarizes the Medicare contractor guidance discussed in the article and the related documentation considerations.
-
Caution
Notes that coding should align with the specific encounter and the provider’s assessment.
What You Will Learn
- How a payer-related Q&A can inform E/M risk discussions
- Why documentation of ongoing drug monitoring matters
- How provider assessment fits into E/M coding support
- What type of audience a contractor interpretation may be relevant to
Who Should Read This
- Medical coders
- Billing staff
- Compliance auditors
- Physicians and other clinicians
- Practice managers
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com